tbuckley/cabot-search huggingface dataset:
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
Authors: Sonja H Brunvoll, Anders B Nygaard, Merete Ellingjord-Dale, Petter Holland, Mette Stausland Istre, Karl Trygve Kalleberg, Camilla L Søraas, Kirsten B Holven, Stine M Ulven, Anette Hjartåker, Trond Haider, Fridtjof Lund-Johansen, John Arne Dahl, Haakon E Meyer, Arne Søraas
Journal: BMJ (2022)

Abstract Objective To determine if daily supplementation with cod liver oil, a low dose vitamin D supplement, in winter, prevents SARS-CoV-2 infection, serious covid-19, or other acute respiratory infections in adults in Norway. Design Quadruple blinded, randomised placebo controlled trial. Setting Norway, 10 November 2020 to 2 June 2021. Participants 34 601 adults (aged 18-75 years), not taking daily vitamin D supplements. Intervention 5 mL/day of cod liver oil (10 µg of vitamin D, n=17 278) or placebo (n=17 323) for up to six months. Main outcome measures Four co-primary endpoints were predefined: the first was a positive SARS-CoV-2 test result determined by reverse transcriptase-quantitative polymerase chain reaction and the second was serious covid-19, defined as self-reported dyspnoea, admission to hospital, or death. Other acute respiratory infections were indicated by the third and fourth co-primary endpoints: a negative SARS-CoV-2 test result and self-reported symptoms. Side effects related to the supplementation were self-reported. The fallback method was used to handle multiple comparisons. Results Supplementation with cod liver oil was not associated with a reduced risk of any of the co-primary endpoints. Participants took the supplement (cod liver oil or placebo) for a median of 164 days, and 227 (1.31%) participants in the cod liver oil group and 228 (1.32%) participants in the placebo group had a positive SARS-CoV-2 test result (relative risk 1.00, multiple comparison adjusted confidence interval 0.82 to 1.22). Serious covid-19 was identified in 121 (0.70%) participants in the cod liver oil group and in 101 (0.58%) participants in the placebo group (1.20, 0.87 to 1.65). 8546 (49.46%) and 8565 (49.44%) participants in the cod liver oil and placebo groups, respectively, had ≥1 negative SARS-CoV-2 test results (1.00, 0.97 to 1.04). 3964 (22.94%) and 3834 (22.13%) participants in the cod liver oil and placebo groups, respectively, reported ≥1 acute respiratory infections (1.04, 0.97 to 1.11). Only low grade side effects were reported in the cod liver oil and placebo groups. Conclusion Supplementation with cod liver oil in the winter did not reduce the incidence of SARS-CoV-2 infection, serious covid-19, or other acute respiratory infections compared with placebo. Trial registration ClinicalTrials.gov NCT04609423 .
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
Authors: David A Jolliffe, Hayley Holt, Matthew Greenig, Mohammad Talaei, Natalia Perdek, Paul Pfeffer, Giulia Vivaldi, Sheena Maltby, Jane Symons, Nicola L Barlow, Alexa Normandale, Rajvinder Garcha, Alex G Richter, Sian E Faustini, Christopher Orton, David Ford, Ronan A Lyons, Gwyneth A Davies, Frank Kee, Christopher J Griffiths, John Norrie, Aziz Sheikh, Seif O Shaheen, Clare Relton, Adrian R Martineau
Journal: BMJ (2022)

To determine the effect of population level implementation of a test-and-treat approach to correction of suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) <75 nmol/L) on risk of all cause acute respiratory tract infection and covid 19.Phase 3 open label randomised controlled trial.United Kingdom.6200 people aged ≥16 years who were not taking vitamin D supplements at baseline.Offer of a postal finger prick test of blood 25(OH)D concentration with provision of a six month supply of lower dose vitamin D (800 IU/day, n=1550) or higher dose vitamin D (3200 IU/day, n=1550) to those with blood 25(OH)D concentration <75 nmol/L, compared with no offer of testing or supplementation (n=3100). Follow-up was for six months.The primary outcome was the proportion of participants with at least one swab test or doctor confirmed acute respiratory tract infection of any cause. A secondary outcome was the proportion of participants with swab test confirmed covid-19. Logistic regression was used to calculate odds ratios and associated 95% confidence intervals. The primary analysis was conducted by intention to treat.Of 3100 participants offered a vitamin D test, 2958 (95.4%) accepted and 2674 (86.3%) had 25(OH)D concentrations <75 nmol/L and received vitamin D supplements (n=1328 lower dose, n=1346 higher dose). Compared with 136/2949 (4.6%) participants in the no offer group, at least one acute respiratory tract infection of any cause occurred in 87/1515 (5.7%) in the lower dose group (odds ratio 1.26, 95% confidence interval 0.96 to 1.66) and 76/1515 (5.0%) in the higher dose group (1.09, 0.82 to 1.46). Compared with 78/2949 (2.6%) participants in the no offer group, 55/1515 (3.6%) developed covid-19 in the lower dose group (1.39, 0.98 to 1.97) and 45/1515 (3.0%) in the higher dose group (1.13, 0.78 to 1.63).Among people aged 16 years and older with a high baseline prevalence of suboptimal vitamin D status, implementation of a population level test-and-treat approach to vitamin D supplementation was not associated with a reduction in risk of all cause acute respiratory tract infection or covid-19.ClinicalTrials.gov NCT04579640.
Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort
Authors: Charlotte Debras, Eloi Chazelas, Laury Sellem, Raphaël Porcher, Nathalie Druesne-Pecollo, Younes Esseddik, Fabien Szabo de Edelenyi, Cédric Agaësse, Alexandre De Sa, Rebecca Lutchia, Léopold K Fezeu, Chantal Julia, Emmanuelle Kesse-Guyot, Benjamin Allès, Pilar Galan, Serge Hercberg, Mélanie Deschasaux-Tanguy, Inge Huybrechts, Bernard Srour, Mathilde Touvier
Journal: BMJ (2022)

Abstract Objectives To study the associations between artificial sweeteners from all dietary sources (beverages, but also table top sweeteners, dairy products, etc), overall and by molecule (aspartame, acesulfame potassium, and sucralose), and risk of cardiovascular diseases (overall, coronary heart disease, and cerebrovascular disease). Design Population based prospective cohort study (2009-21). Setting France, primary prevention research. Participants 103 388 participants of the web based NutriNet-Santé cohort (mean age 42.2±14.4, 79.8% female, 904 206 person years). Dietary intakes and consumption of artificial sweeteners were assessed by repeated 24 h dietary records, including brand names of industrial products. Main outcomes measures Associations between sweeteners (coded as a continuous variable, log10 transformed) and cardiovascular disease risk, assessed by multivariable adjusted Cox hazard models. Results Total artificial sweetener intake was associated with increased risk of cardiovascular diseases (1502 events, hazard ratio 1.09, 95% confidence interval 1.01 to 1.18, P=0.03); absolute incidence rate in higher consumers (above the sex specific median) and non-consumers was 346 and 314 per 100 000 person years, respectively. Artificial sweeteners were more particularly associated with cerebrovascular disease risk (777 events, 1.18, 1.06 to 1.31, P=0.002; incidence rates 195 and 150 per 100 000 person years in higher and non-consumers, respectively). Aspartame intake was associated with increased risk of cerebrovascular events (1.17, 1.03 to 1.33, P=0.02; incidence rates 186 and 151 per 100 000 person years in higher and non-consumers, respectively), and acesulfame potassium and sucralose were associated with increased coronary heart disease risk (730 events; acesulfame potassium: 1.40, 1.06 to 1.84, P=0.02; incidence rates 167 and 164; sucralose: 1.31, 1.00 to 1.71, P=0.05; incidence rates 271 and 161). Conclusions The findings from this large scale prospective cohort study suggest a potential direct association between higher artificial sweetener consumption (especially aspartame, acesulfame potassium, and sucralose) and increased cardiovascular disease risk. Artificial sweeteners are present in thousands of food and beverage brands worldwide, however they remain a controversial topic and are currently being re-evaluated by the European Food Safety Authority, the World Health Organization, and other health agencies. Trial registration ClinicalTrials.gov NCT03335644
Re: Christian Fuglesang S. Jensen, Dana A. Ohl, Mikkel Fode, et al. Microdissection Testicular Sperm Extraction Versus Multiple Needle-pass Percutaneous Testicular Sperm Aspiration in Men with Nonobstructive Azoospermia: A Randomized Clinical Trial. Eur Urol. 2022;82:377–384
Authors: Bo Li, Chen Duan, Xiangyang Yao, Xiaoliang Wu, Hua Xu
Journal: European Urology (2022)
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges
Authors: John A King, Ajay Desai, Tom Semple, Andrew G Nicholson, Andrew Bush, Samatha Sonnappa
Journal: Thorax (2022)

We present two neonates requiring extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension, highlighting the clinical and ethical dilemmas in management of very rare diseases.
EP04.01-011 Diagnostic Approach and Treatment of Lung Cancer Patients in Portugal: Portuguese Lung Cancer Study Group Survey
Authors: F. Estevinho, A. Figueiredo, E. Teixeira, J. Oliveira, A. Pego, A. Barroso, A. Faria, A. Fernandes, A. Chaves, A. Araújo, A. Meleiro, B. Parente, C. Matos, D. Canário, E. Camacho, F. Barata, G. Câmara, H. Queiroga, J. Lopes, J. Mellidez, L. Barradas, L. Ferreira, L. Ferreira, M. Felizardo, M. Figueiredo, M. Soares, M. Lopes, N. Gil, P. Fidalgo, R. Gomes, R. Vitorino, S. Valente, S. Silva, T. Cardoso, U. Brito, T. Almodovar
Journal: Journal of Thoracic Oncology (2022)
EP06.01-008 COVID-Protected Pathways for Image Guided Lunc Cancer Intervention During the COVID-19 Pandemic: A Cohort Study
Authors: A. Sheeka, A. Singaravelou, E. Bartlett, N. Sivarasan, B. Rawal, A. Devaraj, S. Desai, S. Padley, C. Ridge
Journal: Journal of Thoracic Oncology (2022)
EP06.01-017 Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
Authors: Y. Garitaonaindía Díaz, M. Blanco Clemente, M. Martínez-Cutillas, M. Gil Barturen, V. Calvo, A. Collazo-Lorduy, J.L. Campo Cañaveral, F. Franco, C. Traseira, R. Aguado, G. Visedo, M.M. Sanchez del Corral, D. Ruiz de Domingo, A. Gonzalez-Sanchez, M. Provencio
Journal: Journal of Thoracic Oncology (2022)
EP04.01-005 Lung Cancer Diagnosis Following Emergency Admission: Diagnostic and Therapeutic Pathways and Outcomes Within an Italian Cancer Center
Authors: G. Vallome, I. Cafaro, A. Bottini, L. Del Mastro, P. Pronzato, A. Sobrero, A. Ballestrero, A. Bellodi, P. Moscatelli, E. Barisione, C. Genova
Journal: Journal of Thoracic Oncology (2022)
EP07.01-018 Phase III Randomized Trial on Surgery, Chemo and Pleural Radiation (IMPRINT) for Resectable Pleural Mesothelioma (NRG LU-006)
Authors: A. Rimner, C. Hu, C.B. Simone, V.W. Rusch, M.G. Zauderer, R.R. Gill, E.D. Yorke, Z. Li, K.R. Voong, T. Peikert, M.S. Tsao, R. Paulus, J.D. Bradley
Journal: Journal of Thoracic Oncology (2022)
EP08.01-034 Association of Sarcopenia with Survival in Advanced NSCLC Patients Receiving Concurrent Immunotherapy and Chemotherapy
Authors: F.J. Bolte, S. McTavish, N. Wakefield, L. Shantzer, C. Hubbard, A. Krishnaraj, W. Novicoff, R. Hall
Journal: Journal of Thoracic Oncology (2022)
EP04.02-002 International Consensus on Actions to Improve Lung Cancer Survival: Delphi Method in the International Cancer Benchmarking Partnership
Authors: C. Lynch, S. Harrison, J. Butler, D. Baldwin, P. Dawkins, J. van der Horst, E. Jakobsen, J. McAleese, A. McWilliams, K. Redmond, A. Swaminath, C. Finley
Journal: Journal of Thoracic Oncology (2022)
EP04.01-026 Cone-Beam CT Guided Navigation Bronchoscopy: a Cost-Effective Modality for the Diagnosis of Pulmonary Nodules
Authors: S. Kops, R.L.J. Verhoeven, R.J. Vermeulen, M.M. Rovers, E.H.F.M. van der Heijden, T.M. Govers
Journal: Journal of Thoracic Oncology (2022)
EP07.01-017 Malignant Fibrous Solitary Tumour of the Pleura Is Not All the Same: Evaluation of Risk Stratification Models in a Large Single Centre Series
Authors: S. Ricciardi, D. Giovanniello, M. Di Martino, F. Carleo, M.O. Jaus, S. Mantovani, L. Salvadori, M.T. Aratari, L. Carbone, A.R. De Massimi, S. Treggiari, G. Cardillo
Journal: Journal of Thoracic Oncology (2022)
EP08.02-109 A Drug-Drug Interaction Study of Mobocertinib and Midazolam in Patients With Advanced Non-Small Cell Lung Cancer
Authors: M.J. Hanley, S. Zhang, N. Pavlakis, R. Soo, A.J. van der Wekken, V. Ganju, A. Pina, Q. Dong, N. Gupta
Journal: Journal of Thoracic Oncology (2022)
EP04.01-008 Factors Impacting Time from Biopsy to Initiation of Treatment for Advanced NSCLC at an Academic Hospital and Affiliate Hospitals
Authors: C. Vakkalagadda, D. Dressler, Z. Sun, M. Kocherginsky, P. Silberman, Y. Boumber, Y.K. Chae, N.A. Mohindra, A. Ragam, J. Patel
Journal: Journal of Thoracic Oncology (2022)
EP05.01-023 Feasibility of Functional Lung Avoidance using Ga-68 4D Ventilation Perfusion PET/CT: The HI-FIVE Trial
Authors: N.W. Bucknell, N. Hardcastle, B. Woon, M. Bressel, K. Byrne, L. Selbie, J. Callahan, G.G. Hanna, M.S. Hofman, D. Ball, T. Kron, S. Siva
Journal: Journal of Thoracic Oncology (2022)
TCT-95 Role of Pulmonary Artery Catheter Utilization in Different SCAI Classifications in Patients With Acute Myocardial Infarction and Cardiogenic Shock: Analysis From a Large US Healthcare System
Authors: Mohit Pahuja, Aakash Tuli, Akhil Kallur, Abhinav Saxena, Adam Johnson, Cheng Zhang, Steven Rappaport, Hayder Hashim, Lowell Satler, Itsik Ben-Dor, Ron Waksman
Journal: Journal of the American College of Cardiology (2022)
TCT-126 Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention of the Left Anterior Descending Artery
Authors: Michael Megaly, Samer Zakhour, Judit Karacsonyi, Mir Basir, Katherine Kunkel, Bahadir Simsek, Spyridon Kostantinis, Kambis Mashayekhi, David Kandzari, Emmanouil Brilakis, Khaldoon Alaswad
Journal: Journal of the American College of Cardiology (2022)
TCT-503 Objective Quantification of Post-TAVR Aortic Regurgitation in the Real World Using 12 Different Types of Transcatheter Heart Valves: A Multicenter Pooled Analysis
Authors: Mahmoud Abdelshafy, Patrick Serruys, Ahmed Elkoumy, Hesham Elzomor, Pruthvi Chenniganahosahalli Revaiah, Nicola Corcione, Igor Belluschi, Won-Keun Kim, Andreas Rück, Francesco Maisano, Yoshinobu Onuma, Darren Mylotte, Osama Soliman
Journal: Journal of the American College of Cardiology (2022)
TCT-401 Clinical Feature and Long-Term Mortality of Severe Degenerative Aortic Valve Stenosis With Low Aortic Valve Calcification Following Aortic Valve Replacement
Authors: Yeonwoo Choi, Hoyun Kim, Mijin Kim, Jinsun Park, Jinho Lee, Jung-Min Ahn, Dong Hyun Yang, Do-Yoon Kang, Joon Bum Kim, Duk-Woo Park, Dae-Hee Kim, Seung-Jung Park
Journal: Journal of the American College of Cardiology (2022)
TCT-155 The Bioadaptor RCT Study: Comparison of a Novel Sirolimus-Eluting Bioadaptor With Zotarolimus-Eluting Stent in De Novo Coronary Arteries
Authors: Shigeru Saito, Holger Nef, Mark Webster, Mengping Zhu
Journal: Journal of the American College of Cardiology (2022)
TCT-485 Calcium Severity Increases Stent Eccentricity and Bioprosthetic Leaflet Pinwheeling and Stress Following Simulated TAVR for Bicuspid Aortic Valves
Authors: Breandan Yeats, Venkateshwar Polsani, Pradeep Yadav, Vinod Thourani, Lakshmi Dasi
Journal: Journal of the American College of Cardiology (2022)
TCT-572 Impact of Evolocumab on the Pharmacodynamic Effects of Clopidogrel in Patients With Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Authors: Luis Ortega-Paz, Fabiana Rollini, Latonya Been, Andrea Rivas, Naji Maaliki, Andres Pineda, Siva Suryadevara, Daniel Soffer, Martin Zenni, Dominick Angiolillo, Francesco Franchi
Journal: Journal of the American College of Cardiology (2022)
TCT-568 Contemporary Trends of Racial and Social Disparities in Left Atrial Appendage Closure Procedure: Insights From the National Inpatient Sample
Authors: Ahmed Maraey, Nabila Khalil, Sarah Fathy, Wael Abdelmottaleb, Mahmoud Khalil, Ahmed Younes, Ahmed Elzanaty
Journal: Journal of the American College of Cardiology (2022)
TCT-196 PCI Versus CABG for Left Main Disease in Patients Presenting With Versus Without an Acute Coronary Syndrome
Authors: Prakriti Gaba, Evald Christiansen, Sabina Murphy, Patrick O’Gara, Patrick Serruys, Arie Kappetein, Seung-Jung Park, Duk-Woo Park, Gregg Stone, Mark Sabatine, Niels Holm, Brian Bergmark
Journal: Journal of the American College of Cardiology (2022)
TCT-576 Serum Cholesterol Levels Do Not Influence Lipid Core Burden Index
Authors: Frans Mensink, Jan Los, Mohamed Reda, Jeroen Jaspers Focks, Rohit Oemrawsingh, Peter Damman, Marleen van Wely, Helmut Gehlmann, Niels van Royen, Robert-Jan Van Geuns
Journal: Journal of the American College of Cardiology (2022)
TCT-399 Impact of Mechanism of TAVR Failure on Outcomes after Reintervention for Failed TAVR: Insights From the EXPLANTORREDO-TAVR International Registry
Authors: Syed Zaid, Shinichi Fukuhara, Mateo Marin-Cuartas, Ole De Backer, Oliver Bhadra, Kendra Grubb, Emily Shih, David Meier, Sachin Goel, Gilbert Tang
Journal: Journal of the American College of Cardiology (2022)
TCT-317 Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-associated Pathophysiological Mechanism. The LEARNER Study
Authors: Daniela Trabattoni, Marta Brambilla, Paola Canzano, Giovanni Teruzzi, Manuela Muratori, Calogero Tedesco, Alessia Becchetti, Susanna Fiorelli, Piero Montorsi, Marina Camera
Journal: Journal of the American College of Cardiology (2022)
TCT-128 Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention
Authors: Spyridon Kostantinis, Bahadir Simsek, Judit Karacsonyi, Khaldoon Alaswad, Michael Megaly, Farouc Jaffer, Jaikirshan Khatri, Paul Poommipanit, Rhian Davies, Stephane Rinfret, Basem Elbarouni, Luiz Ybarra, Abdul Sheikh, Catalin Toma, Raj Chandwaney, Omer Goktekin, Ahmed ElGuindy, Olga Mastrodemos, Bavana Rangan, M. Nicholas Burke, Emmanouil Brilakis
Journal: Journal of the American College of Cardiology (2022)
TCT-273 Relationship Between Coronary Volume, Myocardial Mass and Post-PCI Fractional Flow Reserve
Authors: Hirofumi Ohashi, Niya Mileva, Pasquale Paolisso, Jonathon Leipsic, Takuya Mizukami, Jeroen Sonck, Bjarne Norgaard, Hiromasa Otake, Brian Ko, Michael Maeng, Koshiro Sakai, Daniel Munhoz, Sakura Nagumo, Marta Belmonte, Dobrin Vassilev, Emanuele Barbato, Bon-Kwon Koo, Bernard De Bruyne, Carlos Collet
Journal: Journal of the American College of Cardiology (2022)
TCT-206 Mechanical Thrombectomy Versus Catheter Directed Thrombolysis in Patients Presenting With Submassive Pulmonary Embolism: A Multi-Center Experience
Authors: Michael Bashline, Errol Inci, Sameer Khandhar, Matthew Herzig, Wissam Jaber, Catalin Toma
Journal: Journal of the American College of Cardiology (2022)
TCT-504 Quantitative Angiographic Assessment of Post-TAVR Residual Aortic Regurgitation in Patients Treated With Portico vs Navitor Transcatheter Heart Valve: Independent Core Lab Analysis
Authors: Ahmed Elkoumy, Nicola Corcione, Mahmoud Abdelshafy, Hesham Elzomor, Michele Albanese, Alberto Morello, Pruthvi Chenniganahosahalli Revaiah, Michele Cimmino, Won-Keun Kim, Patrick Serruys, Osama Soliman
Journal: Journal of the American College of Cardiology (2022)
TCT-540 Novel Contrast Calculator Tool to Prevent Contrast Nephropathy Post–Percutaneous Coronary Intervention
Authors: Alan Zajarias, Marc Sintek, John Lasala, Prashanth Thakker, Howard Kurz, Richard Bach, Nathan Frogge, Mary Caruso, Kathleen Schlafly, Casey Rowe, Samantha Miller
Journal: Journal of the American College of Cardiology (2022)
TCT-363 Incidence and Timing of Device-Related Thrombus in Percutaneous Implantable Cardiac Devices: A Systematic Review and Meta-Analysis
Authors: Richard Jung, Trevor Simard, Taylor Gillmore, Mina Rizk, Pietro Di Santo, Joanne Joseph, Cameron Stotts, Pouya Motazedian, Graeme Prosperi-Porta, Omar Abdel-Razek, Simon Parlow, Melissa Lepage-Ratte, Risa Shorr, Francisco Ramirez, Mohamad Alkhouli, Josep Rodes-Cabau, David Holmes, Benjamin Hibbert
Journal: Journal of the American College of Cardiology (2022)
TCT-376 Holographic Mixed Reality Image Analysis vs CT Reconstruction for Assessment of Aortic Valve Complex in Patients Undergoing TAVR
Authors: Michela Bonanni, Marco Desiati, Giulio Russo, Gianluca Massaro, Daniela Benedetto, Sofia Schino, Marco Di Luozzo, Enrica Mariano, Massimo Marchei, Maurizio Taramasso, Francesco Maisano, Giuseppe Sangiorgi
Journal: Journal of the American College of Cardiology (2022)
TCT-475 Moderate to Severe Mitral Regurgitation’s Impact on One-Year Mortality After Transcatheter Aortic Valve Replacement
Authors: Bishoy Abraham, Ayman Fath, Michael Megaly, Chieh-Ju Chao, Reza Arsanjani, F. David Fortuin, John Sweeney, Mohamad Alkhouli, Patricia Pellikka, Vuyisile Nkomo, David Holmes, Said Alsidawi
Journal: Journal of the American College of Cardiology (2022)
TCT-366 Comparison of Hemodynamic Performance of Transcatheter Aortic Valve Replacement with Supra-Annular Self-Expanding Versus Balloon-Expandable Valves Assessed by Exercise Cardiovascular Magnetic Resonance
Authors: Luis Augusto Palma Dallan, Guilherme Attizzani, Sung-Han Yoon, Rafey Feroze, Varun Rajagopalan, Christian Baeza, Marc Pelletier, Sadeer Al-Kindi, Sanjay Rajagopalan, Imran Rashid
Journal: Journal of the American College of Cardiology (2022)
TCT-289 Age-Related Differences in Coronary Microvascular Dysfunction and Spasm in Patients With Angina and No Obstructive Coronary Artery Disease (ANOCA)
Authors: Aukelien Dimitriu-Leen, Tijn Jansen, Regina Konst, Laura Rodwell, Jihane Bourich, Stijn van den Oord, Angela Maas, Niels van Royen, Peter Damman
Journal: Journal of the American College of Cardiology (2022)
TCT-122 Revascularization Versus Optimal Medical Therapy on Left Ventricular Ischemia Reduction: Exploring the Associations Between Ischemia, Functional Outcome, and Collaterals in the Treatment of Chronic Total Occlusion Patients: Rationale and Design of the REVISE-CTO Trial
Authors: Anna van Veelen, Joelle Elias, Bimmer Claessen, René van der Schaaf, Stijn Brinckman, Hein Verberne, Paul Knaapen, Jose Henriques
Journal: Journal of the American College of Cardiology (2022)
TCT-48 Left Ventricular Recovery Among Patients With Acute Anterior ST-Segment Elevation Myocardial Infarction Treated With Impella
Authors: Adrian Attinger-Toller, Dhanya Kalathil, Dario Winterton, Giacomo Maria Cioffi, Mehdi Madanchi, Thomas Seiler, Francesca Goffredo, Patrick Fankhauser, Federico Moccetti, Stefan Toggweiler, Richard Kobza, Florim Cuculi, Matthias Bossard, Gregorio Tersalvi
Journal: Journal of the American College of Cardiology (2022)
TCT-188 Safety and Efficacy of Intravascular Lithotripsy in the Management of Stent Underexpansion Among Elderly Patients
Authors: Mariusz Tomaniak, Janusz Kochman, Rafał Januszek, Rafał Wolny, Maksymilian Opolski, Łukasz Kuźma, Lukasz Lewicki, Jacek Bil, Jan Kulczycki, Adrian Wlodarczak, Brunon Tomasiewicz, Sylwia Iwanczyk, Jerzy Sacha, Lukasz Koltowski, Milosz Dziarmaga, Milosz Jaguszewski, Pawel Kralisz, Grzegorz Sobieszek, Krzysztof Dyrbus, Piotr Wańczura, Mariusz Łebek, Krzysztof Reczuch, Tomasz Pawlowski, Robert Gil, Slawomir Dobrzycki, Piotr Kwiatkowski, Mariusz Gąsior, Andrzej Ochala, Adam Witkowski, Maciej Lesiak, Fabrizio D’Ascenzo, Stanislaw Bartus, Wojciech Wojakowski, Wojciech Wańha
Journal: Journal of the American College of Cardiology (2022)